IL161307A0 - Silicon compounds - Google Patents
Silicon compoundsInfo
- Publication number
- IL161307A0 IL161307A0 IL16130702A IL16130702A IL161307A0 IL 161307 A0 IL161307 A0 IL 161307A0 IL 16130702 A IL16130702 A IL 16130702A IL 16130702 A IL16130702 A IL 16130702A IL 161307 A0 IL161307 A0 IL 161307A0
- Authority
- IL
- Israel
- Prior art keywords
- silicon compounds
- silicon
- compounds
- Prior art date
Links
- 150000003377 silicon compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
- C07F7/0836—Compounds with one or more Si-OH or Si-O-metal linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0126036.3A GB0126036D0 (en) | 2001-10-30 | 2001-10-30 | Silicon compounds |
PCT/GB2002/004900 WO2003037905A1 (en) | 2001-10-30 | 2002-10-30 | Silicon compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161307A0 true IL161307A0 (en) | 2004-09-27 |
Family
ID=9924797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16130702A IL161307A0 (en) | 2001-10-30 | 2002-10-30 | Silicon compounds |
Country Status (16)
Country | Link |
---|---|
US (1) | US20050020541A1 (xx) |
EP (1) | EP1440076A1 (xx) |
JP (1) | JP2005507425A (xx) |
KR (1) | KR20050042000A (xx) |
CN (1) | CN1578782A (xx) |
AU (1) | AU2002339071B2 (xx) |
BR (1) | BR0213731A (xx) |
CA (1) | CA2464997A1 (xx) |
GB (1) | GB0126036D0 (xx) |
HU (1) | HUP0401699A2 (xx) |
IL (1) | IL161307A0 (xx) |
MX (1) | MXPA04003968A (xx) |
PL (1) | PL370584A1 (xx) |
RU (1) | RU2004116347A (xx) |
WO (1) | WO2003037905A1 (xx) |
ZA (1) | ZA200403197B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7595308B2 (en) * | 2002-11-18 | 2009-09-29 | Grenpharma Llc | Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
WO2004075902A1 (en) * | 2003-02-28 | 2004-09-10 | Amedis Pharmaceuticals Ltd. | Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder |
WO2004094436A1 (en) * | 2003-04-24 | 2004-11-04 | Amedis Pharmaceuticals Ltd. | 1-(2-amino-1-phenyl-ethyl) 1- silacyclohexan-1- ol derivatives and use thereof in the preparation of a medicament |
US7816372B2 (en) | 2003-08-22 | 2010-10-19 | Ligand Pharmaceuticals Incorporated | 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
WO2005090282A1 (en) | 2004-03-12 | 2005-09-29 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
WO2005118551A2 (en) | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
CA2586681A1 (en) * | 2004-10-22 | 2006-05-04 | Thomas C. Pochapsky | Compositions for treating and/or preventing diseases characterized by the presence of the metal ions |
AU2005299720B2 (en) | 2004-10-25 | 2010-02-04 | Ligand Pharmaceuticals Incorporated | Thrombopoietin activity modulating compounds and methods |
CN101137655A (zh) | 2005-06-17 | 2008-03-05 | 配体药物公司 | 雄激素受体调节剂化合物和方法 |
GB2441581B (en) * | 2005-06-24 | 2011-01-19 | Roderic M K Dale | Compositions and methods for the treatment of muscle wasting |
US8680150B2 (en) | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
DK2488486T3 (da) | 2009-10-13 | 2019-11-18 | Ligand Pharm Inc | Småmolekylære forbindelser der efterligner hæmapoetisk vækstfaktor og anvendelse deraf |
WO2012068406A2 (en) | 2010-11-18 | 2012-05-24 | Ligand Pharmaceuticals Incorporated | Use of hematopoietic growth factor mimetics |
CN109293551A (zh) | 2011-11-14 | 2019-02-01 | 利亘制药公司 | 与粒细胞集落刺激因子受体相关的方法和组合物 |
WO2014150252A1 (en) | 2013-03-15 | 2014-09-25 | Ligand Pharmaceuticals Incorporated | Methods of treatment associated with the granulocyte colony-stimulating factor receptor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56324B1 (en) * | 1982-12-13 | 1991-06-19 | American Home Prod | Phenethylamine derivatives and intermediates therefor |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US4611078A (en) * | 1983-10-26 | 1986-09-09 | American Home Products Corporation | Substituted phenylacetonitriles |
US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
-
2001
- 2001-10-30 GB GBGB0126036.3A patent/GB0126036D0/en not_active Ceased
-
2002
- 2002-10-30 WO PCT/GB2002/004900 patent/WO2003037905A1/en not_active Application Discontinuation
- 2002-10-30 JP JP2003540186A patent/JP2005507425A/ja not_active Ceased
- 2002-10-30 HU HU0401699A patent/HUP0401699A2/hu unknown
- 2002-10-30 AU AU2002339071A patent/AU2002339071B2/en not_active Expired - Fee Related
- 2002-10-30 US US10/493,977 patent/US20050020541A1/en not_active Abandoned
- 2002-10-30 BR BR0213731-3A patent/BR0213731A/pt not_active IP Right Cessation
- 2002-10-30 RU RU2004116347/04A patent/RU2004116347A/ru not_active Application Discontinuation
- 2002-10-30 CA CA002464997A patent/CA2464997A1/en not_active Abandoned
- 2002-10-30 EP EP02777453A patent/EP1440076A1/en not_active Withdrawn
- 2002-10-30 PL PL02370584A patent/PL370584A1/xx not_active Application Discontinuation
- 2002-10-30 IL IL16130702A patent/IL161307A0/xx unknown
- 2002-10-30 CN CNA028217349A patent/CN1578782A/zh active Pending
- 2002-10-30 MX MXPA04003968A patent/MXPA04003968A/es not_active Application Discontinuation
- 2002-10-30 KR KR1020047005901A patent/KR20050042000A/ko not_active Application Discontinuation
-
2004
- 2004-04-28 ZA ZA200403197A patent/ZA200403197B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005507425A (ja) | 2005-03-17 |
KR20050042000A (ko) | 2005-05-04 |
MXPA04003968A (es) | 2005-01-25 |
ZA200403197B (en) | 2005-04-28 |
US20050020541A1 (en) | 2005-01-27 |
BR0213731A (pt) | 2004-10-19 |
PL370584A1 (en) | 2005-05-30 |
GB0126036D0 (en) | 2001-12-19 |
CA2464997A1 (en) | 2003-05-08 |
RU2004116347A (ru) | 2005-05-10 |
AU2002339071B2 (en) | 2005-08-11 |
WO2003037905A1 (en) | 2003-05-08 |
CN1578782A (zh) | 2005-02-09 |
HUP0401699A2 (hu) | 2004-12-28 |
EP1440076A1 (en) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002349297A8 (en) | Statin-like compounds | |
GB0101996D0 (en) | Organtic compounds | |
GB0112324D0 (en) | Compounds | |
GB0102668D0 (en) | Compounds | |
GB0127430D0 (en) | Compounds | |
IL161307A0 (en) | Silicon compounds | |
GB0108102D0 (en) | Compounds | |
GB0102673D0 (en) | Compounds | |
GB0102665D0 (en) | Compounds | |
EP1458669A4 (en) | ACTIVE COMPOUNDS ON THE NEUROLOGICAL PLAN | |
GB0118364D0 (en) | Compounds | |
GB0115178D0 (en) | Compounds | |
GB0328020D0 (en) | Silicon compounds | |
GB0108097D0 (en) | Compounds | |
GB0126035D0 (en) | Silicon compounds | |
GB0126037D0 (en) | Silicon compounds | |
GB0201618D0 (en) | Silicon compounds | |
GB0105098D0 (en) | Compounds | |
GB0226753D0 (en) | Silicon compounds | |
GB0226754D0 (en) | Silicon compounds | |
GB0225376D0 (en) | Silicon compounds | |
GB0126389D0 (en) | Wafer | |
GB0119424D0 (en) | Compounds | |
GB0116059D0 (en) | Compounds | |
GB0106673D0 (en) | Compounds |